- Report
- January 2025
- 194 Pages
Global
From €7029EUR$7,950USD£6,064GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2466EUR$2,789USD£2,127GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2466EUR$2,789USD£2,127GBP
- Report
- October 2021
- 61 Pages
Global
From €4377EUR$4,950USD£3,776GBP
- Report
- May 2024
- 131 Pages
Global
From €5746EUR$6,499USD£4,957GBP
- Report
- October 2021
- 157 Pages
Global
From €3935EUR$4,450USD£3,394GBP
- Report
- March 2024
- 30 Pages
Global
From €2431EUR$2,750USD£2,098GBP
- Report
- June 2023
- 159 Pages
Global
From €6631EUR$7,500USD£5,721GBP
- Report
- May 2024
- 160 Pages
Global
From €4393EUR$4,969USD£3,790GBP
- Report
- January 2024
Asia Pacific
From €1326EUR$1,500USD£1,144GBP
- Report
- October 2022
- 67 Pages
North America
From €1326EUR$1,500USD£1,144GBP
- Report
- June 2023
- 97 Pages
Global
From €3500EUR$4,240USD£3,125GBP
- Report
- November 2021
- 392 Pages
Global
From €2653EUR$3,000USD£2,288GBP
- Report
- November 2021
- 747 Pages
Global
From €3537EUR$4,000USD£3,051GBP
- Report
- November 2021
- 844 Pages
Global
From €4421EUR$5,000USD£3,814GBP
- Book
- December 2021
- 576 Pages
- Book
- February 2024
- 928 Pages

The Blood Brain Barrier (BBB) is a specialized membrane that separates the brain from the rest of the body. It is composed of tightly packed cells that form a barrier to protect the brain from potentially harmful substances. The BBB is an important factor in the development of Central Nervous System (CNS) drugs, as it can limit the effectiveness of certain drugs. To overcome this, drug developers must create drugs that can cross the BBB and reach the target area in the brain. This requires a deep understanding of the BBB and its components, as well as the development of new drug delivery systems.
The BBB market is an important part of the CNS drug market, as it provides the necessary tools to develop effective drugs. Companies in this market include AbbVie, AstraZeneca, Biogen, Eli Lilly, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more